Skip to main content
. Author manuscript; available in PMC: 2021 Feb 24.
Published in final edited form as: J Acquir Immune Defic Syndr. 2020 Aug 1;84(4):414–421. doi: 10.1097/QAI.0000000000002360

TABLE 1.

Demographic and Clinical Characteristics

Variable Frail (n = 20) Nonfrail (n = 85) P
Demographic
 Age (yrs) (SD) 55.2 (8.31) 55.8 (7.26) 0.76
 Sex (% male/female) 70% 88% 0.04
 Race (% African American) 70% 58% 0.11
 Education (yr) (SD) 12.5 (2.53) 13.6 (2.7) 0.11
HIV disease
 Duration of HIV infection (mo) (SD) 214 (85) 209 (107) 0.83
 Undetectable viral load (<50 copies/mL), % 85% 91%
 Current CD4 count (cells/mm3), median (IQR) 688 (348.9) 528 (248.9) 0.02
 Nadir CD4 count (cells/mm3), median (IQR) 230 (200.0) 91 (182.36) 0.05
Health comorbidities
 Affective BDI-II subscale (SD) 4.0 (2.9) 1.7 (2.0) 0.003
 Hepatitis C coinfection, % 25% 12% 0.13
Neurocognitive performances
 Global: mean (SD) −0.44 (0.7) −0.25 (0.6) 0.22
 Executive function: mean (SD) −0.54 (0.7) −0.33 (0.7) 0.21
 Psychomotor/Processing speed: mean (SD) −0.31 (0.8) 0.02 (0.7) 0.07
 Memory: mean (SD) −0.71 (1.1) −0.39 (0.9) 0.19
 Learning: mean (SD) −0.76 (1.0) −0.53 (0.9) 0.33
 Language: mean (SD) 0.12 (1.0) −0.04 (0.8) 0.47

Bold indicates P < 0.05.

IQR, interquartile rating.